Biology Reference
In-Depth Information
Brousseau M, Leleu X, Gerard J, Gastinne T, Godon A, Genevieve F, Dib M, Lai JL, Facon T,
Zandecki M (2007) Hyperdiploidy is a common finding in monoclonal gammopathy of
undetermined significance and monosomy 13 is restricted to these hyperdiploid patients. Clin
Cancer Res 13:6026-6031
Carmena M, Earnshaw WC (2003) The cellular geography of aurora kinases. Nat Rev Mol Cell
Biol 4:842-854
Carmena M, Ruchaud S, Earnshaw WC (2009) Making the Auroras glow: regulation of Aurora A
and B kinase function by interacting proteins. Curr Opin Cell Biol 21:796-805
Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, Stewart JP, Zhan F, Khatry D,
Protopopova M, Protopopov A, Sukhdeo K, Hanamura I, Stephens O, Barlogie B, Anderson
KC, Chin L, Shaughnessy JD Jr, Brennan C, Depinho RA (2006) High-resolution genomic
profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer
Cell 9:313-325
Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li YQ, Tarapore P,
Fukasawa K (1999) Centrosome hyperamplification in human cancer: chromosome instability
induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935-1944
Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD (2002) CP110, a cell cycle-dependent
CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3:339-350
Ching YP, Chan SF, Jeang KT, Jin DY (2006) The retroviral oncoprotein Tax targets the coiled-coil
centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol 8:717-724
Chng WJ, Van Wier SA, Ahmann GJ, Winkler JM, Jalal SM, Bergsagel PL, Chesi M, Trendle
MC, Oken MM, Blood E, Henderson K, Santana-Davila R, Kyle RA, Gertz MA, Lacy MQ,
Dispenzieri A, Greipp PR, Fonseca R (2005) A validated FISH trisomy index demonstrates
the hyperdiploid and nonhyperdiploid dichotomy in MGUS. Blood 106:2156-2161
Chng WJ, Ahmann GJ, Henderson K, Santana-Davila R, Greipp PR, Gertz MA, Lacy MQ,
Dispenzieri A, Kumar S, Rajkumar SV, Lust JA, Kyle RA, Zeldenrust SR, Hayman SR,
Fonseca R (2006a) Clinical implication of centrosome amplification in plasma cell neoplasm.
Blood 107:3669-3675
Chng WJ, Ketterling RP, Fonseca R (2006b) Analysis of genetic abnormalities provides insights
into genetic evolution of hyperdiploid myeloma. Genes Chromosom Cancer 45:1111-1120
Chng WJ, Price-Troska T, Gonzalez-Paz N, Van Wier S, Jacobus S, Blood E, Henderson K, Oken
M, Van Ness B, Greipp P, Rajkumar SV, Fonseca R (2007) Clinical significance of TP53
mutation in myeloma. Leukemia 21:582-584
Chng WJ, Braggio E, Mulligan G, Bryant B, Remstein E, Valdez R, Dogan A, Fonseca R (2008a)
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of
patients that might benefit from aurora kinase inhibition. Blood 111:1603-1609
Chng WJ, Gonzalez-Paz N, Price-Troska T, Jacobus S, Rajkumar SV, Oken MM, Kyle RA,
Henderson KJ, Van Wier S, Greipp P, Van Ness B, Fonseca R (2008b) Clinical and biological
significance of RAS mutations in multiple myeloma. Leukemia 22:2280-2284
Cho JH, Chang CJ, Chen CY, Tang TK (2006) Depletion of CPAP by RNAi disrupts centrosome
integrity and induces multipolar spindles. Biochem Biophys Res Commun 339:742-747
Christensen JH, Abildgaard N, Plesner T, Nibe A, Nielsen O, Sorensen AG, Kerndrup GB (2007)
Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal
gammopathy of undetermined significance without and with positive plasma cell identifica-
tion: analysis of 192 cases from the Region of Southern Denmark. Cancer Genet Cytogenet
174:89-99
Crainie M, Belch AR, Mant MJ, Pilarski LM (1999) Overexpression of the receptor for
hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple
myeloma: identification of three distinct RHAMM variants. Blood 93:1684-1696
International Myeloma Working Group (2003) Criteria for the classification of monoclonal
gammopathiesmultiple myeloma and related disorders: a report of the international myeloma
working group. Br J Haematol 121:749-757
Dai W, Wang Q, Traganos F (2002) Polo-like kinases and centrosome regulation. Oncogene
21:6195-6200
